Antifibrotic effects of pioglitazone at low doses on the diabetic rat kidney are associated with the improvement of markers of cell turnover, tubular and endothelial integrity, and angiogenesis.

Toblli JE, Cao G, Giani JF, Angerosa M, Dominici FP, Gonzalez-Cadavid NF. Antifibrotic effects of pioglitazone at low doses on the diabetic rat kidney are associated with the improvement of markers of cell turnover, tubular and endothelial integrity, and angiogenesis. Kidney Blood Press Res. 2011; 34(1):20-33.

View in: PubMed

subject areas

Animals
Antifibrinolytic Agents
Diabetes Mellitus, Type 2
Diabetic Nephropathies
Dose-Response Relationship, Drug
Endothelium, Vascular
Kidney Tubules
Male
Neovascularization, Physiologic
Rats
Rats, Zucker
Thiazolidinediones

authors with profiles

Nestor F. Gonzalez-Cadavid, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support